Successful use of second cord blood transplantation to achieve long-term remission in cord blood donor cell-derived AML harboring a FLT3-ITD and an NPM1 mutation.
K
K
Chonabayashi
T
T
Kondo
K
K
Yamamoto
Y
Y
Tanaka
Y
Y
Nagai
M
M
Hishizawa
A
A
Takaori-Kondo
D001483:Base Sequence; D001782:Blood Donors; D036101:Cord Blood Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000209:etiology / Q000235:genetics / Q000601:surgery*; D008969:Molecular Sequence Data; D016609:Neoplasms, Second Primary / Q000209:etiology / Q000235:genetics / Q000601:surgery; D009687:Nuclear Proteins / Q000235:genetics*; D000090243:Nucleophosmin; D051941:fms-Like Tyrosine Kinase 3 / Q000235:genetics*
C000716967:NPM1 protein, human; D009687:Nuclear Proteins; D000090243:Nucleophosmin; C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3